These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 22781123

  • 1. Chronic respiratory disease, inhaled corticosteroids and risk of non-tuberculous mycobacteriosis.
    Andréjak C, Nielsen R, Thomsen VØ, Duhaut P, Sørensen HT, Thomsen RW.
    Thorax; 2013 Mar; 68(3):256-62. PubMed ID: 22781123
    [Abstract] [Full Text] [Related]

  • 2. The risk of mycobacterial infections associated with inhaled corticosteroid use.
    Brode SK, Campitelli MA, Kwong JC, Lu H, Marchand-Austin A, Gershon AS, Jamieson FB, Marras TK.
    Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28931659
    [Abstract] [Full Text] [Related]

  • 3. Increased risk of nontuberculous mycobacterial infection in asthmatic patients using long-term inhaled corticosteroid therapy.
    Hojo M, Iikura M, Hirano S, Sugiyama H, Kobayashi N, Kudo K.
    Respirology; 2012 Jan; 17(1):185-90. PubMed ID: 21995339
    [Abstract] [Full Text] [Related]

  • 4. Inhaled Corticosteroids and Mycobacterial Infection in Patients with Chronic Airway Diseases: A Systematic Review and Meta-Analysis.
    You Y, Ni Y, Shi G.
    Respiration; 2022 Jan; 101(10):970-980. PubMed ID: 35998604
    [Abstract] [Full Text] [Related]

  • 5. Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD.
    Thornton Snider J, Luna Y, Wong KS, Zhang J, Chen SS, Gless PJ, Goldman DP.
    Curr Med Res Opin; 2012 Dec; 28(12):1959-67. PubMed ID: 23098081
    [Abstract] [Full Text] [Related]

  • 6. [The clinical analysis of chronic obstructive pulmonary disease patients complicated with nontuberculous mycobacterial pulmonary disease].
    Sun YX, Shao C, Li S, Xu K, Huang H, Xu ZJ.
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Nov 12; 42(11):826-831. PubMed ID: 31694092
    [Abstract] [Full Text] [Related]

  • 7. Comorbid pulmonary disease and risk of community-acquired pneumonia in COPD patients.
    Lin SH, Ji BC, Shih YM, Chen CH, Chan PC, Chang YJ, Lin YC, Lin CH.
    Int J Tuberc Lung Dis; 2013 Dec 12; 17(12):1638-44. PubMed ID: 24200282
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Use of inhaled corticosteroids and the risk of tuberculosis.
    Lee CH, Kim K, Hyun MK, Jang EJ, Lee NR, Yim JJ.
    Thorax; 2013 Dec 12; 68(12):1105-13. PubMed ID: 23749841
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of inhaled corticosteroids in monotherapy or combined with long-acting {beta}2-agonists on mortality among patients with chronic obstructive pulmonary disease.
    Cyr MC, Beauchesne MF, Lemière C, Aaron SD, Blais L.
    Ann Pharmacother; 2010 Apr 12; 44(4):613-22. PubMed ID: 20233915
    [Abstract] [Full Text] [Related]

  • 12. Risks of pneumonia in patients with asthma taking inhaled corticosteroids.
    O'Byrne PM, Pedersen S, Carlsson LG, Radner F, Thorén A, Peterson S, Ernst P, Suissa S.
    Am J Respir Crit Care Med; 2011 Mar 01; 183(5):589-95. PubMed ID: 20889908
    [Abstract] [Full Text] [Related]

  • 13. Association between Inhaled Corticosteroid Use and Pulmonary Nontuberculous Mycobacterial Infection.
    Liu VX, Winthrop KL, Lu Y, Sharifi H, Nasiri HU, Ruoss SJ.
    Ann Am Thorac Soc; 2018 Oct 01; 15(10):1169-1176. PubMed ID: 30213194
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inhaled drugs as risk factors for community-acquired pneumonia.
    Almirall J, Bolíbar I, Serra-Prat M, Palomera E, Roig J, Hospital I, Carandell E, Agustí M, Ayuso P, Estela A, Torres A, Community-Acquired Pneumonia in Catalan Countries.
    Eur Respir J; 2010 Nov 01; 36(5):1080-7. PubMed ID: 20525710
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Relationships between COPD and nontuberculous mycobacteria pulmonary infections].
    Balavoine C, Andréjak C, Marchand-Adam S, Blanc FX.
    Rev Mal Respir; 2017 Dec 01; 34(10):1091-1097. PubMed ID: 29150178
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Increased risk of pulmonary tuberculosis in patients with previous non-tuberculous mycobacterial disease.
    Hsing SC, Weng SF, Cheng KC, Shieh JM, Chen CH, Chiang SR, Wang JJ.
    Int J Tuberc Lung Dis; 2013 Jul 01; 17(7):928-33. PubMed ID: 23743312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.